PSMA-SulfoCy7

Overview

PSMA-SulfoCy7 is a high-affinity imaging agent targeting PSMA/GCPII (with a K i of 18.1 nM for human PSMA ). PSMA-SulfoCy7 regulates PSMA-dependent NAAG hydrolysis. PSMA-SulfoCy7 exhibits excellent in vivo imaging capability, enabling clear visualization of PSMA-expressing tumors in xenograft models, with no obvious toxicity even at a dose of 87.9 mg/kg. PSMA-SulfoCy7 is widely used in prostate cancer-related studies.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > PSMA

Product Information

• Catalog No.: HY-D3353
• CAS No.: 2766510-90-9
• Molecular Formula: C90H112ClN13O20S2
• Molecular Weight: 1795.51
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source